1-苊胺 | 40745-44-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 1-苊胺
• 英文名称: 1-aminoacenaphthene
• 英文别名: acenaphthen-1-ylamine；Acenaphthen-1-ylamin；1-Amino-acenaphthen；1,2-dihydro-1-acenaphthylenamine；acenaphthen-1-yl-amine；2-Amino-acenaphthen；1,2-Dihydroacenaphthylen-1-amine
• CAS: 40745-44-6
• 化学式: C₁₂H₁₁N
• 分子量: 169.226
• InChiKey: LCYNDXQWJAMEAI-UHFFFAOYSA-N

物化性质

• 熔点：
  81 ºC
• 沸点：
  288.52°C (rough estimate)
• 密度：
  1.187

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921499090

反应信息

• 作为反应物：
  描述：

  1-苊胺 在 potassium carbonate 、 溶剂黄146 作用下， 以 乙醇 为溶剂， 生成 (RS)-1-(acenaphthen-1-yl)-4-(3-methoxy-phenylamino)-piperidine-4-carbonitrile
  参考文献：
  名称：

  8-Acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists

  摘要：

  A series of 8-acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivatives 1 was studied with respect to the binding affinity for the orphanin FQ (OFQ) and opioid (mu, kappa, delta) receptors. The influence of stereochemistry as well as the substitution pattern of the phenyl-ring in position 1 on the affinity for the orphanin FQ receptor and selectivity to opioid (mu, kappa, delta) receptors is discussed. The most interesting compound Ic was tested for its anxiolytic-like properties in vivo. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00385-6
• 作为产物：
  描述：

  1-萘乙酸 在 aluminum (III) chloride sodium tetrahydroborate 、 氯化亚砜 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 三苯基膦 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 水 、 1,2-二氯乙烷 、 甲苯 为溶剂， 反应 15.0h， 生成 1-苊胺
  参考文献：
  名称：

  REMEDY FOR SLEEP DISTURBANCE

  摘要：

  公开号：

  EP1491212B1

文献信息

• Identification of (S)-selective transaminases for the asymmetric synthesis of bulky chiral amines
  作者：Ioannis V. Pavlidis、Martin S. Weiß、Maika Genz、Paul Spurr、Steven P. Hanlon、Beat Wirz、Hans Iding、Uwe T. Bornscheuer

  DOI：10.1038/nchem.2578

  日期：2016.11

  to 8,900-fold higher activity than the starting scaffold and are highly stereoselective (up to >99.9% enantiomeric excess) in the asymmetric synthesis of a set of chiral amines bearing bulky substituents. These enzymes should therefore be suitable for use in the synthesis of a wide array of potential intermediates for pharmaceuticals. We also show that the motif can be engineered into other protein

  使用转氨酶来获得药学上相关的手性胺是过渡金属催化的不对称化学合成的一种有吸引力的替代方法。然而，一个主要的挑战是它们有限的基板范围。在这里，我们报道了从I类折叠开始创建的高活性和立体选择性转氨酶。转氨酶是通过广泛的蛋白质工程开发的，然后对所鉴定的基序进行了优化。在一组带有庞大取代基的手性胺的不对称合成中，所得的酶显示出比起始支架高多达8900倍的活性，并且具有高度的立体选择性（对映体过量高达> 99.9％）。因此，这些酶应适合用于合成多种潜在的药物中间体。
• PROCESS FOR PREPARING 1-(4-PIPERIDINYL)BENZIMIDAZOLONE DERIVATIVES
  申请人：Iwamura Hiroshi

  公开号：US20110295013A1

  公开（公告）日：2011-12-01

  Provision of an industrial method of producing a 1-(4-piperidinyl)benzimidazolone derivative in a high yield at a low cost. A production method of 1-(4-piperidinyl)benzimidazolone derivative (1) or a salt thereof according to the following steps. [step 1] a step of subjecting a piperidone compound (2) and an aniline compound (3) to a reductive amination reaction to give to a compound (4) [step 2] a step of reacting the compound (4) with di-t-alkyl dicarbonate or N,N′-disuccinimidyl carbonate to give the 1-(4-piperidinyl)benzimidazolone derivative (1) wherein R 1 is optionally substituted alkyl or an optionally substituted cyclic group, and R 2 is optionally substituted alkyl, optionally substituted alkenyl or optionally substituted aryl.

  提供一种工业方法，以低成本高产率生产1-(4-哌啶基)苯并咪唑酮衍生物。根据以下步骤生产1-(4-哌啶基)苯并咪唑酮衍生物（1）或其盐。[步骤1] 将哌啶酮化合物（2）和苯胺化合物（3）经还原胺化反应得到化合物（4）的步骤[步骤2] 将化合物（4）与二叔丁基二碳酸酯或N,N'-二琥珀酰亚胺碳酸酯反应，得到1-(4-哌啶基)苯并咪唑酮衍生物（1）其中R1可选地为取代烷基或取代环烷基，R2可选地为取代烷基、取代烯烃基或取代芳基。
• Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
  申请人：Gruenenthal GmbH

  公开号：US20040229872A1

  公开（公告）日：2004-11-18

  The use of substituted cyclohexan-1,4-diamine compounds in pharmaceutical compositions and for the treatment of diarrhea or irritable bowel diseases or as immunotherapeutic agents or peripheral analgesics, especially for treating burn pains, peripheral operation pains, pains generated by inflammation of soft tissues or inflammatory arthropathies, especially rheumatisms.

  替代环己烷-1,4-二胺化合物在制药组合物中的使用以及用于治疗腹泻或肠易激综合征或作为免疫治疗剂或周围镇痛剂，特别是用于治疗烧伤疼痛，周围手术疼痛，软组织炎症或炎性关节病引起的疼痛，特别是风湿病的治疗。
• Remedy for sleep disturbance
  申请人：Teshima Koji

  公开号：US20050119308A1

  公开（公告）日：2005-06-02

  The present invention has been made based on the finding that a compound acting on the ORL-1 receptor as an agonist acts as a non-photic entrainment factor, and advances the circadian rhythm phase, and provides a novel therapeutic agent for a sleep disorder such as circadian rhythm sleep disorder, more particularly, an agent for the prophylaxis and/or treatment of a sleep disorder, which contains an ORL-1 receptor agonist, and a novel compound useful as such agent for the prophylaxis and/or treatment.

  本发明是基于发现得出的，即作用于ORL-1受体的化合物作为激动剂时，作为非光周期性调节因子，可以提前昼夜节律阶段，并提供一种新的治疗药物，用于治疗睡眠障碍，如昼夜节律睡眠障碍，更具体地说，是一种用于预防和/或治疗睡眠障碍的药物，其中包含ORL-1受体激动剂，并提供了一种作为该药物预防和/或治疗的有用化合物。
• Pharmaceutically active compounds and methods of use
  申请人：——

  公开号：US20020099084A1

  公开（公告）日：2002-07-25

  The present invention relates to pharmaceutically acceptable compounds, including certain substituted indolinyl and derivatives thereof, 1,2,3,4-tetrahydroquinolinyl and derivatives thereof, 1,2,3,4-tetrahydroisoquinolinyl, benz[cd]indolinyl and 5,6-dihydrophenanthridinyl compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for the treatment or prophylaxis of neurological injury and neurodegenerative disorders.

  本发明涉及药学上可接受的化合物，包括某些取代的吲哚啉及其衍生物、1,2,3,4-四氢喹啉及其衍生物、1,2,3,4-四氢异喹啉、苯并[cd]吲哚啉和5,6-二氢苯并喹啉化合物，以及利用或包含一种或多种这样的化合物的治疗方法和制药组合物。本发明的化合物特别适用于神经损伤和神经退行性疾病的治疗或预防。